You have read all your free articles, to continue reading subscribe to read the rest of this content.
Erwin Brenndörfer has joined LIDDS as Project Manager Translational Medicine. Erwin will be responsible for managing LIDDS portfolio of pre-clinical studies as well as continuing the development of the NanoZolid technology and identifying new drugs that can be combined with NanoZolid. An AssistantAlready a subscriber Login You have read all…
The Board of Directors of Getinge has decided to replace the President & CEO of the Getinge Group, which means that Getinges’ President & CEO Alex Myers is leaving his position. The Board of Directors has appointed Joacim Lindoff as Acting President & CEO. Joacim is currently PresidAlready a subscriber…
The Board of Directors at Bonesupport has appointed Emil Billbäck as the new CEO. Billbäck, who lives in Malmö and is a Swedish citizen, will join from Essity where he was Senior Advisor following its acquisition of BSN Medical from the Swedish private equity group EQT in 2017. Prior to…
The company has eliminated an organizational layer to shorten the decision-making process in the US operations and to create closer collaboration between global and local functions. The role as CEO of Oncopeptides, Inc. will no longer be a designated company function and as a consequence, Joseph Already a subscriber Login…
